HomeIMMX • NASDAQ
Immix Biopharma Inc
add
$1.57
7.19%
After Hours:(5.43%)-0.085
$1.48
Closed: Apr 11, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.99M | -7.23% |
Net income | -4.81M | 5.45% |
Net profit margin | — | — |
Earnings per share | -0.15 | 37.50% |
EBITDA | -4.97M | 7.56% |
Effective tax rate | -0.22% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.68M | 0.98% |
Total assets | 22.95M | 15.17% |
Total liabilities | 9.70M | 160.54% |
Total equity | 13.25M | — |
Shares outstanding | 27.72M | — |
Price to book | 3.04 | — |
Return on assets | -51.85% | — |
Return on capital | -75.64% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -4.81M | 5.45% |
Cash from operations | -1.48M | 44.87% |
Cash from investing | -507.15K | -3,748.76% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -2.01M | 3.10% |
Free cash flow | -207.80K | 78.17% |
Previous close
$1.46
Day range
$1.36 - $1.64
Year range
$1.26 - $2.88
Market cap
43.47M USD
Avg Volume
51.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2012
Headquarters
Website
Employees
18
